Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 20 Show results per page	View Search Criteria \| Help With Results


1.		A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 and under				NICHD				PPRU 10762 NCT00491946

Last Modified: 4/21/2008 First Published: 8/24/2003


2.		Phase I/II Study of Donor Lymphocyte Infusion in Patients With Persistent, Relapsed, or Progressing Malignancy After Nonmyeloablative Allogeneic Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Any age				NCI				FHCRC-1803.00 NCT00068718


3.		Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				21 and under				Other				BMT 0499 Solid NCT00179816

Last Modified: 8/23/2008 First Published: 7/1/2001


4.		Phase II Pilot Study of High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation and Immunotherapy With Activated T Cells, Interleukin-2, and Sargramostim (GM-CSF) in Patients With Stage IIIB or IV Breast Cancer or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				WSU-2007-033 NCT00020722, RWMC-0634246


5.		Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				Other				UMCC 9626 IRB 1996-195, NCT00141765


6.		A Pilot Study of Tumor Cell Vaccine for High-Risk Solid Tumor Patients Following Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				30 and under				Other				UMCC 2005.050 GCRC ID # 2191, NCT00405327

Last Modified: 9/3/2008 First Published: 2/14/2008


7.		Phase II Study of Conditioning Regimen Comprising Anti-thymocyte Globulin, Clofarabine, and Rituximab in Patients With Primary or Secondary Graft Failure After Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				NCI				UMN-2007LS072 UMN-2007LS072, UMN-MT2007-07, NCT00617929

Last Modified: 12/10/2007 First Published: 1/1/2002


8.		Phase I Study of Ixabepilone in Young Patients With Refractory Solid Tumors (Closed to Accrual as of 10/4/2007) or Relapsed or Refractory Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				2 to 21				NCI				NCI-02-C-0031E 02-C-0031, 5425, NCI-5425, NCT00030108

Last Modified: 2/11/2008 First Published: 7/7/2006


9.		Phase I Study of Cediranib in Pediatric Patients With Refractory or Recurrent Extracranial Malignant Solid Tumors or Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				2 to 18				NCI, Pharmaceutical / Industry				NCI-06-C-0152 NCI-P6571, NCT00354848, ZENECA-D8480C00016

Last Modified: 7/10/2007 First Published: 1/19/2007


10.		Phase I Study of Lexatumumab in Pediatric Patients With Relapsed or Refractory Solid Tumors or Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				1 to 21				NCI				NCI-07-C-0040 NCI-P6981, NCT00428272

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute